Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

v3.20.2
Revenue Recognition (Tables)
6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The composition of Revenue from services by payor for the six months ended June 30, 2020 and 2019 was as follows:
  Three months ended June 30, Six months ended June 30,
(In thousands) 2020 2019 2020 2019
Healthcare insurers $ 84,082    $ 106,278    $ 183,232    $ 211,207   
Government payers 15,886    28,634    42,784    59,037   
Client payers 141,090    38,101    180,191    76,559   
Patients 9,913    5,445    15,604    10,546   
Total $ 250,971    $ 178,458    $ 421,811    $ 357,349   
Client payers include cities and states for which BioReference provides COVID-19 testing services.
Schedule of Product Sales Allowances and Accruals
The following table presents an analysis of product sales allowances and accruals for the three and six months ended June 30, 2020:
(In thousands) Chargebacks, discounts, rebates and fees Governmental Returns Total
Balance at March 31, 2020 $ 2,863    $ 6,199    $ 3,332    $ 12,394   
  Provision related to current period sales 4,468    9,073    686    14,227   
  Credits or payments made (4,441)   (8,273)   (188)   (12,902)  
Balance at June 30, 2020 $ 2,890    $ 6,999    $ 3,830    $ 13,719   
Total gross Rayaldee sales
$ 22,876   
Provision for Rayaldee sales allowances and accruals as a percentage of gross Rayaldee sales
62  %
(In thousands) Chargebacks, discounts, rebates and fees Governmental Returns Total
Balance at December 31, 2019 $ 3,194    $ 5,841    $ 2,751    $ 11,786   
  Provision related to current period sales 9,293    16,281    1,389    26,963   
  Credits or payments made (9,597)   (15,123)   (310)   (25,030)  
Balance at June 30, 2020 $ 2,890    $ 6,999    $ 3,830    $ 13,719   
Total gross Rayaldee sales
$ 45,559   
Provision for Rayaldee sales allowances and accruals as a percentage of gross Rayaldee sales
59  %